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We report a measles outbreak in two Portuguese health 
regions (Algarve and Lisbon and the Tagus Valley) 
since February 2017, and which by 31 May resulted in 
28 confirmed cases, of which 16 were unvaccinated. 
Thirteen cases were healthcare workers. One unvac-
cinated teenager died. Genotype B3 was identified in 
14 cases from both regions. This outbreak occurs after 
12 years without endemic measles transmission, and 
in a context of high measles vaccination coverage and 
immunity.
We describe a measles outbreak that started in 
February 2017, with 28 confirmed cases, as at 31 May. 
The investigation is ongoing and we present here pre-
liminary findings and the implemented control meas-
ures. After the identification of the first measles case, 
a contingency plan at the Directorate-General of Health 
(Direção-Geral da Saúde, DGS) was implemented, 
following the Portuguese National Programme for 
Measles Elimination (Programa Nacional de Eliminação 
do Sarampo, PNES) [1]. This report is based on data 
extracted on 31 May from the National System for 
Epidemiological Surveillance (Sistema Nacional de 
Vigilância Epidemiológica, SINAVE), which is an inte-
grated clinical and laboratory system of mandatory 
notification.
Vaccination against measles is included in the national 
immunisation programme (Programa Nacional de 
Vacinação, PNV) since 1974 and is available for free. 
This outbreak occurs after a 12-year period without 
endemic measles transmission in Portugal, which led 
the World Health Organization (WHO) Regional Office 
for Europe to certify measles as eliminated in the 
country in 2015 and 2016 [2]. In Portugal, measles is 
a mandatory notifiable disease since 1987 and, within 
the scope of the PNES [1], any suspected measles case 
notified is investigated thoroughly.
Immunity against measles is high in Portugal. The 
National Serological Survey conducted in 2001–02 
showed a proportion of immune individuals above 
93.4% in all age groups [3]. Preliminary results from 
the latest survey (2015–16), show that this trend of 
high immunity was maintained (data not shown).
Case definition
The measles case definition used during this out-
break was based on the European Commission case 
definition [4]. Measles cases were defined as possible, 
probable or confirmed, depending on clinical, epide-
miological and laboratory criteria.
A possible case was any person who met clinical cri-
teria i.e. fever, maculopapular rash, and any of cough/
coryza/conjunctivitis; a probable case was any person 
who met clinical criteria and had an epidemiological 
link to a confirmed case; a confirmed case was any 
possible case with laboratory evidence of infection 
with measles virus i.e. detection of viral RNA in a bio-
logical sample and/or a positive IgM result in serum, 
determined by the WHO-certified national reference 
laboratory for measles and rubella (National Institute 
of Health – Instituto Nacional de Saúde Doutor Ricardo 
Jorge, INSA) [5].
Following the WHO criteria [6], cases were discarded 
when clinical, epidemiological or laboratory criteria 
were not met, taking into account vaccination his-
tory and risk of measles infection in the community or 
abroad.
Outbreak description
As at 31 May, 156 measles cases were notified in 
Portugal in 2017. In the outbreak reported here, 28 
cases were confirmed, seven were classified as possi-
ble, three cases were under investigation and 117 cases 
were discarded. Additionally, one confirmed imported 
measles case was identified in the north health region, 
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which was an isolated case with no epidemiological or 
genotypic links to the cases in the outbreak described 
here.
All possible measles cases notified were investigated 
and control measures were promptly implemented 
in order to contain transmission. This report focuses 
on the description of confirmed cases in Algarve and 
Lisbon and the Tagus Valley (Lisboa e Vale do Tejo, 
LVT), two health regions which are not in close proxim-
ity (Figure 1). 
The distribution of cases over time is described in the 
epidemic curve (Figure 2).
Algarve health region
The first measles case was notified to health authori-
ties on 30 March (rash onset on 21 March), and was 
from the Algarve health region, a touristic region with 
tourists mainly from other European countries. Local 
and regional public health teams immediately initiated 
epidemiological investigations that led to the retro-
spective identification of three additional cases, with 
prior disease onset. Overall, this transmission chain 
comprised seven confirmed cases (Figure 1, 2). The 
earliest case had rash onset on 23 February and the 
latest had rash onset on 8 April. No further confirmed 
cases were identified in Algarve. Five of these cases 
acquired measles in a healthcare setting, including two 
healthcare workers; five cases (4 infants aged under 
1 year and 1 adult) were hospitalised. To date, no epi-
demiological link has been found between this cluster 
and other cases reported in Portugal or abroad.
Lisbon and the Tagus Valley health region
The first case identified in the LVT health region was 
reported by a paediatrician from Cascais Hospital to 
the Regional Department of Public Health and the DGS 
on 6 April (rash onset on 30 March). Twenty-one cases 
were confirmed in LVT health region, with the earliest 
case having had rash onset on 17 March. This case was 
identified due to the epidemiological investigation of 
the first notified case in this region. The last confirmed 
case in the LVT region had developed rash on 13 May 
and no further measles cases were confirmed. The 
transmission chain in the LVT region is under investi-
gation, with epidemiological links already identified 
between most cases. Eleven cases were healthcare 
workers. In the LVT region, seven cases were hospital-
ised, and one death has occurred in an unvaccinated 
teenager.
Characteristics of cases
Most confirmed measles cases (n = 19) occurred in 
adults (≥  18 years), two cases were adolescents (10–
18 years), and seven cases occurred in children (< 10 
years) (Figure 3).
Of note, 13 cases occurred in healthcare workers 
(Table). Of the 28 cases, 16 had not been previously 
vaccinated; while the remaining cases had docu-
mented evidence of one (4 cases) or two or more doses 
(8 cases, including 1 case vaccinated with 3 doses, the 
first one between 6 and 12 months of age) of a measles 
vaccine, either single or combined (Table).
Among the unvaccinated cases, five were infants under 
1 year of age and thus too young to be vaccinated, one 
case was 13 months old, two were adolescents, and 
the remaining eight cases were in adults (Figure 3). 
Thirteen cases were healthcare workers, of which three 
were unvaccinated.
Laboratory investigation
Laboratory investigation was carried out by INSA. A 
variety of samples were used to confirm or discard a 
measles case: serum, oral fluids or throat swabs, or 
urine. Measles cases were confirmed by positive IgM, 
detection of measles nucleic acid or isolation of mea-
sles virus.
Figure 1
Incidence rate of confirmed measles cases per 100,000 
population by health region, Portugal, 23 February–31 
May 2017 (n = 28 confirmed cases)
Incidence rate
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0,3 to 0,6
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Map developed by GeoSaúde (http://www.geosaude.dgs.pt/).
Source: Direção-Geral da Saúde, Sistema Nacional de Vigilância 
Epidemiológica.
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Genotype B3 was identified in 14 cases from Algarve 
and LVT health regions, identical to the genotype 
detected in other outbreaks in Europe in 2017 e.g. in 
Belgium, Italy and the United Kingdom [7,8]. Genotyping 
of the remaining 14 confirmed cases is still ongoing.
Control measures
Following the increasing number of measles cases 
reported in several European countries in early 2017, 
DGS issued a warning to healthcare services, followed 
by recommendations and guidelines about diagnosis, 
early detection and response to measles cases, within 
the scope of the PNES [1].
In Portugal, when a suspected measles case is identi-
fied by health services, the physician is requested to 
fill in an electronic notification form at the SINAVE, 
and an email alert is simultaneously generated for 
local, regional and national public health authori-
ties. Likewise, INSA also notifies DGS of all requests 
for measles tests, and notifies results electronically 
through SINAVE. Additionally, local public health 
units must inform immediately by phone and/or email 
regional and national public health authorities.
In this outbreak, all reported suspected measles cases 
were investigated and control measures were promptly 
implemented in order to contain transmission. While 
transmission could be prevented for imported case 
identified in the north health region, cases in Algarve 
and LVT had already generated transmission chains by 
the time they were reported.
Local public health teams undertook extensive contact 
tracing for all measles cases. Furthermore, surveillance 
and control measures included: immediate isolation of 
suspected cases, verification of immunisation status 
of close contacts, and administration of prophylactic 
immunoglobulin or measles-mumps-rubella (MMR) 
vaccine.
Epidemiological investigations and isolation of cases 
was complemented with broader public health meas-
ures, that included: (i) dissemination of key documents 
– posters about measles clinical picture, guidelines, 
epidemiological bulletins, and background materials 
for healthcare services – to support prevention and 
control measures [9-12]; (ii) creation of a specific sec-
tion on measles on the DGS website [13], together with 
emails to inform healthcare professionals and schools; 
(iii) raising public awareness about the importance of 
vaccination through numerous reports in the media; 
(iv) enhancing vaccination, especially in children < 18 
years and in healthcare workers, according to the PNV 
and PNES guidelines.
Discussion
As at 31 May, 28 laboratory-confirmed measles cases 
were identified in Portugal in 2017. Transmission 
occurred in three different settings: household, com-
munity and healthcare services. Besides interviewing 
patients, hospital staff and family members, public 
health authorities had to liaise with airline companies 
and foreign public health authorities, as one confirmed 
case travelled abroad during the incubation period.
This measles outbreak in a country with high levels of 
reported vaccination coverage and immunity [3,14] rep-
resents a challenge for the Portuguese public health 
authorities. In contrast with many European coun-
tries, Portugal records high uptake of MMR vaccine. 
However, immunity gaps persist, with vulnerable popu-
lation pockets [3,14,15]. We found a relatively large 
proportion of measles cases in vaccinated individuals 
and this has also been reported in other outbreaks 
[16-18]. This situation is expected in highly vaccinated 
communities and might be explained by the fact that 
MMR is not 100% effective, with around 7.5% and 
Figure 2
Confirmed measles cases by week of rash onset, Portugal, 
23 February–31 May 2017 (n = 28)
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Figure 3
Confirmed measles cases by age group, Portugal, 23 
February–31 May 2017 (n = 28)
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5.0% non-respondents to the first and second doses, 
respectively [19].
Mass immunisation campaigns against measles took 
place in Portugal between 1973 and 1977. In 1974, the 
single measles vaccine was introduced in the PNV for 
children aged 12–15 months, and in 1987 the combined 
MMR. Since 1990, two doses of MMR vaccine are rec-
ommended for children. Since 2017, the recommended 
schedule is at 12 months and 5 years of age [20]. Two 
doses are also recommended for healthcare profes-
sionals, and one dose for adults born in or after 1970 
without previous measles history [20]. Portugal has 
achieved sustained immunisation coverage against 
measles, above 95% for one and two doses in < 18-year-
olds [21]. Measles immunity in older age groups was 
above 93% in 2002 [3].
Some delay between disease onset and notification in 
the early measles cases in Algarve and LVT could be 
explained by the fact that physicians might not have 
considered measles as the first diagnosis. This is very 
likely in a country without endemic measles transmis-
sion for more than a decade. After the first notifica-
tions, public health teams retrospectively investigated 
all potential measles cases, leading to the identifica-
tion of four additional cases that had not been notified 
timely. The outbreak however made physicians more 
aware of the measles diagnosis and subsequent cases 
were notified timely.
The accumulation of measles-susceptible population 
pockets in a context of increasing number of outbreaks 
in European countries since 2016 [22,23] could have 
contributed to this outbreak in our country. Thus, pos-
sible links between these cases and other outbreaks 
in Europe are under investigation. The outbreak has 
increased national awareness and knowledge about 
measles diagnosis and epidemiological investigations, 
enhanced vaccination activities at the local level, and 
also motivated demand for vaccination from the gen-
eral population and healthcare workers. The high 
and increasing number of notified possible measles 
cases being discarded in the course of this outbreak, 
increases confidence about its control. The last con-
firmed measles case in this outbreak was notified in 
the LVT health region on 14 May (rash onset on 13 May). 
No further confirmed cases linked to this case have 
been notified to date.
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